【レポートの概要（一部）】
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 8
1.2 List of Figures 8
2 Introduction 9
2.1 What Is This Report About? 9
3 Definitions of Markets/Categories Covered 10
3.1 Nephrology and Urology Devices 10
3.1.1 Renal Dialysis Equipment 10
4 Company Snapshot 11
4.1 Key Facts 11
4.2 Company Overview 11
4.3 Financial Performance 11
4.4 Business Overview 12
4.5 Major Products and Services 13
4.5.1 Overview 13
5 History 14
6 Competitors 16
7 Competitive Landscape 17
7.1 Nephrology and Urology Devices (Renal Dialysis Equipment), Global, Market Share (%), 2011 17
7.2 NxStage Medical, Inc., Nephrology and Urology Devices (Category), by Region, Market Share (2011) 19
7.3 NxStage Medical, Inc., Nephrology and Urology Devices (Category), by Country, Market Share (2011) 20
8 Key Employees 22
9 Key Employee Biographies 23
10 Company Statement 24
11 Locations And Subsidiaries 27
11.1 Head Office 27
11.2 Other Locations & Subsidiaries 27
12 Financial Deals Landscape 28
12.1 NxStage Medical, Inc., Deals Volume Summary, 2007 to YTD 2013 28
13 NxStage Medical, Inc., Deals Summary By Region, 2007 to YTD 2013 29
14 NxStage Medical, Inc. Detailed Deal Summary 31
14.1 Partnerships 31
14.1.1 Asahi Kasei Kuraray Medical Enters Into Licensing Agreement With NxStage Medical 31
14.1.2 NxStage Medical Enters Into Distribution Agreement With Dirinco 32
14.1.3 Medisystems Extends Supply And Distribution Agreement With Fenwal 33
14.1.4 Medisystems Enters Into An Agreement With Gambro 34
14.1.5 NxStage Medical Signs An Agreement With Kimal 35
14.1.6 NxStage Medical and DaVita Enter Into An Agreement For Home Hemodialysis 36
14.2 Equity Offering 37
14.2.1 NxStage Medical Completes Public Offering Of Common Stock For $66.1 Million 37
14.2.2 NxStage Medical Completes Private Placement Of $43 Million 38
14.2.3 NxStage Completes Private Placement Of $20 Million 39
14.3 Acquisition 40
14.3.1 NxStage Medical Acquires Medisystems 40
15 Recent Developments 41
15.1 Strategy And Business Planning 41
15.1.1 Oct 16, 2012: NxStage Opens New Headquarters In Lawrence, Massachusetts 41
15.1.2 Jun 17, 2009: NxStage Signs Distribution Agreement With Gambro 41
15.2 Financial Announcements 42
15.2.1 Nov 08, 2012: NxStage Reports Revenue Of $61.12m In Q3 2012 42
15.2.2 Aug 08, 2012: NxStage Reports Revenue Of $59m In Q2 2012 42
15.2.3 May 08, 2012: NxStage Reports Revenue Of $57m In Q1 2012 43
15.2.4 Feb 29, 2012: NxStage Reports Revenue Of $217.3m In 2011 44
15.2.5 Nov 03, 2011: NxStage Reports Revenues Of $559m In Q3 2011 45
15.2.6 Aug 03, 2011: NxStage Reports Revenues Of $53.8m In Q2 2011 46
15.2.7 May 04, 2011: NxStage Reports Revenues Of $50.6m In Q1 2011 46
15.2.8 Feb 17, 2011: NxStage Reports Revenues Of $179.2m In 2010 47
15.2.9 Nov 04, 2010: NxStage Reports Revenues Of $45m In Q3 2010 48
15.2.10 Jul 23, 2010: NxStage Reports Revenues Of $44m In Q2 2010 48
15.2.11 May 05, 2010: NxStage Reports Revenues Of $40.4 Million In Q1 2010 49
15.2.12 Feb 25, 2010: NxStage Reports Revenue Of $148.7 Million In 2009 49
15.2.13 Nov 05, 2009: NxStage Reports Net Revenue Of $38 Million In Q3 2009 50
15.2.14 Aug 05, 2009: NxStage Reports Revenues Of $36.4 Million In Q2 2009 51
15.2.15 May 08, 2009: NxStage Posts Net Loss Of $12.2 Million In Q1 2009 52
15.2.16 Mar 12, 2009: NxStage Reports 2008 Results 53
15.2.17 Feb 03, 2009: NxStage To Report 2008 Results 54
15.2.18 Nov 03, 2008: NxStage Reports 3Q 2008 Results 54
15.2.19 Aug 05, 2008: NxStage Reports 2Q 2008 Results 56
15.2.20 May 12, 2008: NxStage Reports Q1 2008 Results 57
15.2.21 Feb 12, 2008: NxStage Reports Q4 2007 Results 58
15.2.22 Nov 02, 2007: NxStage Reports Q3 2007 Results 60
15.2.23 Aug 02, 2007: NxStage Reports Q2 2007 Results 60
15.2.24 May 08, 2007: NxStage Reports Q1 2007 Results 61
15.2.25 Feb 15, 2007: NxStage Reports Q4 2006 Results 62
15.3 Corporate Communications 63
15.3.1 Jul 12, 2011: NxStage Medical Appoints Barry Straube To Board 63
15.3.2 Apr 27, 2011: NxStage Medical Appoints Michael Miller As President, International 63
15.3.3 Jan 24, 2011: NxStage Appoints Nancy Ham To Board And Announces Resignation Of Board Member Jonathan Silverstein 64
15.3.4 Dec 20, 2010: NxStage Promotes Joseph Turk As President, North America 64
15.3.5 Feb 23, 2010: NxStage Appoints Elise A. Tordella As VP And General Manager 65
15.3.6 Jan 19, 2010: NxStage Appoints John Mullen As Vice President And General Manager, International 65
15.3.7 Oct 28, 2008: NxStage Announces Board Changes 66
15.3.8 Jul 24, 2008: NxStage Appoints New Board Member 66
15.3.9 Mar 31, 2008: NxStage Appoints Senior Vice President, Manufacturing Operations 67
15.3.10 Feb 28, 2008: NxStage Appoints CCMA 67
15.4 Government and Public Interest 68
15.4.1 May 09, 2011: NxStage Supports Initiative By Patient Advocacy Groups To Educate Policymakers About Benefits Of Frequent Home Hemodialysis 68
15.4.2 Nov 22, 2010: Landmark Study In New England Journal Of Medicine Documents Significant Clinical Advantages Of More Frequent Hemodialysis: NxStage 68
15.5 Product News 69
15.5.1 May 24, 2012: NxStage Medical Announces Latest Interim Results From FREEDOM Study Of NxStage System One 69
15.5.2 May 11, 2012: CDRG Study Shows NxStage Daily Home Hemodialysis Patients More Likely To Receive Kidney Transplant 70
15.5.3 Aug 15, 2011: NxStage Announces Seven Year Anniversary Of IU Health’s Home Hemodialysis Program And Patient Milestones 71
15.5.4 Aug 02, 2011: NxStage Patient Advocate Jim Smith Begins West Coast Home Hemodialysis Tour With NxStage System 71
15.5.5 Jun 13, 2011: NxStage Announces Successful Kidney Transplant With NxStage System One 72
15.5.6 May 04, 2011: NxStage Announces TGA Approval And Distribution Agreement In Australia And New Zealand For System One 73
15.5.7 Apr 28, 2011: CDRG Study Shows Daily Home Hemodialysis Therapy With NxStage System One Lowers Risk Of Mortality 73
15.5.8 Feb 21, 2011: Independent Study Reports 50% Smaller Carbon Footprint With NxStage System One Versus Standard In-Center Hemodialysis Machines: NxStage 74
15.5.9 Feb 20, 2011: NxStage Medical Announces Interim Results From Ongoing FREEDOM Study Of NxStage System One 75
15.5.10 Feb 17, 2011: NxStage Announces Over 5,000 Patients Using System One For Home Hemodialysis 76
15.5.11 Jan 10, 2011: NxStage Receives FDA Clearance For Therapeutic Plasma Exchange Cartridge For Use With NxStage System One In Clinical Environment 76
15.5.12 Mar 08, 2010: NxStage Unveils Interim Results Of FREEDOM Study For NxStage System One 77
15.5.13 Feb 03, 2010: NxStage Forms Alliance With Nordic For Distribution Of NxStage System One And PureFlow SL Dialysate Preparation System 78
15.5.14 Dec 15, 2009: Group Of NxStage Home Hemodialysis Patients Plans Conventional Caribbean Cruise Trip With NxStage System One 78
15.5.15 Oct 27, 2009: NxStage Presents The Interim Results From FREEDOM Study Of NxStage System One 79
15.5.16 Nov 05, 2008: NxStage To Present The Interim Results Of The FREEDOM Study At American Society Of Nephrology Meeting 80
15.5.17 Nov 03, 2008: NxStage Achieves Milestone With 3,000 End-Stage Renal Disease Patients Receiving Daily Home Hemodialysis Therapy 80
15.5.18 Oct 24, 2008: NxStage Medical Reports Positive Interim Quality Of Life Results From Landmark FREEDOM Study 80
15.6 Product Approvals 81
15.6.1 May 04, 2011: NxStage Announces TGA Approval And Distribution Agreement In Australia And New Zealand For System One 81
15.6.2 Jan 10, 2011: NxStage Receives FDA Clearance For Therapeutic Plasma Exchange Cartridge For Use With NxStage System One In Clinical Environment 81
15.7 Clinical Trials 82
15.7.1 May 24, 2012: NxStage Medical Announces Latest Interim Results From FREEDOM Study Of NxStage System One 82
15.7.2 May 11, 2012: CDRG Study Shows NxStage Daily Home Hemodialysis Patients More Likely To Receive Kidney Transplant 82
15.7.3 Apr 28, 2011: CDRG Study Shows Daily Home Hemodialysis Therapy With NxStage System One Lowers Risk Of Mortality 83
15.7.4 Feb 20, 2011: NxStage Medical Announces Interim Results From Ongoing FREEDOM Study Of NxStage System One 84
15.7.5 Mar 08, 2010: NxStage Unveils Interim Results Of FREEDOM Study For NxStage System One 85
15.7.6 Oct 27, 2009: NxStage Presents The Interim Results From FREEDOM Study Of NxStage System One 86
15.7.7 Nov 05, 2008: NxStage To Present The Interim Results Of The FREEDOM Study At American Society Of Nephrology Meeting 87
15.7.8 Oct 24, 2008: NxStage Medical Reports Positive Interim Quality Of Life Results From Landmark FREEDOM Study 87
15.8 Other Significant Developments 87
15.8.1 Jul 26, 2011: NxStage Signs Five-Year Agreement With Theradial For Distribution Of System One Home Hemodialysis System In France 87
15.8.2 Jun 27, 2011: NxStage Medical Signs Lease For New Headquarters 88
15.8.3 Nov 30, 2010: NxStage Medical’s Medisystems Division Signs Distribution Agreement With Metro Medical 88
15.8.4 Jul 19, 2010: NxStage Commercializes NxStage System One And Certain Of Company’s In-Center Products In Italy Through Spindial 88
15.8.5 Apr 12, 2010: NxStage Medical’s Medisystems Division Expands Supply Agreement With RAI 89
15.8.6 Sep 14, 2009: NxStage Medical Signs Three-Year Supply Agreement With Reliant Renal Care 90
15.8.7 Jul 21, 2009: NxStage Extends Medisystems Needle Supply And Distribution Agreement With Fenwal 90
15.8.8 Jun 17, 2009: NxStage Signs Five-Year Distribution Agreement With Gambro 91
15.8.9 Jun 01, 2009: NxStage Expands Supply Agreement With B. Braun To Include Streamline Technology 91
15.8.10 May 07, 2009: NxStage And Kimal Announce First International Distribution of NxStage’s Home Hemodialysis And Critical Care Systems 92
15.8.11 Feb 27, 2009: iSirona Signs Agreement With NxStage 92
15.8.12 Oct 21, 2008: NxStage Signs Product Supply Contract With RAI 93
15.8.13 Sep 04, 2008: NxStage Extends Supply Contract With DaVita To Supply Blood Tubing Sets 93
15.8.14 Jan 07, 2008: NxStage Signs Supply Agreement With DaVita 93
16 Appendix 94
16.1 Research Methodology 95
16.2 Secondary Research 95
16.3 Primary Research 95
16.4 Models 96
16.5 Forecasts 96
16.6 Expert Panels 96
16.7 GlobalData Consulting 96
16.8 Currency Conversion 97
16.9 Contact Us 98
16.10 Disclaimer 98
【レポート販売概要】
■ タイトル：NxStage Medical, Inc.：市場シェア分析■ 英文：NxStage Medical, Inc. Market Share Analysis
■ 発行日：2013年1月25日
■ 調査会社：GlobalData
■ 商品コード：GDATA403160147
■ 調査対象地域：グローバル
- 集光型太陽光発電（CPV）のグローバル市場（2014-2018）About Solar Concentrated Photovoltaics A solar CPV system concentrates sunlight on solar cells with the help of an optical device, increasing the efficiency of photovoltaic cells that convert energy from sunlight directly into electricity. The optics used concentrates the sunlight by a factor of 500 to 1,000 and focuses it on the solar cells, which are reduced to a small fraction of the CPV module …
- 第VIII因子欠乏症治療の世界市場2017-2021About Factor VIII Factor VIII is an essential blood-clotting protein, which is also known as an antihemophilic factor. In individuals, factor VIII is encoded by F8 gene. Defects in F8 gene lead to hemophilia A, a recessive X-linked coagulation disorder. Factor VIII is generated in liver sinusoidal cells and endothelial cells outside the liver across the body. This protein mixes in the bloodstream …
- 文房具・カードの世界市場2016-2020About the Stationery and Cards Market The demand for stationery and cards market grows in line with changing demographics, developments in the economy, lifestyle changes, technological innovations, and seasonal and cyclic trends. The market has witnessed a significant change since the evolution of electronic media. While stationery has evolved to become a niche market with an assortment of supplie …
- 世界のビジネスブロードバンド調査サービス （年間購読）TeleGeography’s Business Broadband Research Service is an extensive database of broadband service providers, plans, and prices.
- ランジェリー（肌着類）ネット通販の世界市場About Online Lingerie Market The term lingerie originated from the French word 'linge' for linen. In French, the term is used for both male and female undergarments, whereas in English it refers solely to women's innerwear. Lingerie is made of fabrics like nylon, satin, silk, polyester, and lace. The evolving fashion landscape and the rising focus on comfort have resulted in increased demand for l …
- 汎用検査装置（GPTE）の世界市場ABSTRACTAbout General Purpose Test Equipment General purpose test equipment (GPTE) includes different testing and measuring (T&M) equipment such as oscilloscopes, spectrum analyzers, signal generators, power meters, logic analyzers, electronic counters, and multimeters. Industries such as the communications and aerospace and defense use GPTE for testing their design prototypes and finished product …
- 熱伝導性プラスチックの世界市場予測（～2021）The thermally conductive plastics market is projected to reach USD 255.1 Million by 2021, at a CAGR of 13.6% from 2016 to 2021. The growth of the market is majorly driven by increasing demand for the plastics in the manufacturing of LED lights, lightweight heat sinks, electrical vehicles, medical devices, and lightweight automotive vehicles. These plastics provide design flexibility in comparison …
- 世界の完全置換型人工心臓市場：医療機器パイプライン分析2016Total Artificial Heart - Medical Devices Pipeline Assessment, 2016 Summary GlobalData's Medical Devices sector report, “Total Artificial Heart - Medical Devices Pipeline Assessment, 2016" provides an overview of Total Artificial Heart currently in pipeline stage. The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of de …
- 世界の航空用・軍事用補助動力装置(APU)市場About Aerospace and Military APU An APU is used when an aircraft is on the ground to provide ground power, hydraulics, air conditioning, and air to start engines. Most of the APUs use centrifugal compressors. They work by spinning an impeller that throws the air outward through a convergent duct with diffuser veins to direct the compressed gas on to the combustion chamber. These APUs are even foun …
- ポリオレフィンの世界市場2017-2021About Polyolefins Polyolefins are the biggest class of commodity thermoplastics. These polymers are made of simple alkenes, which include ethylene, propylene, butenes, and pentenes, and their copolymers. Polyethylene (PE) and polypropylene (PP) are the two most widely used polyolefins in the world. Technavio’s analysts forecast the global polyolefins market to grow at a CAGR of 7.48% during the pe …
- 認知機能評価及びトレーニングの世界市場予測Cognitive assessment primarily is the assessment of cognitive capabilities to estimate an individual’s intellectual functioning. It involves various tests administered to the individual to determine a wide range of abilities such as memory, problem-solving skills, language skills, and other intellectual capabilities. Pen and paper-based assessment, hosted assessment and training tools, biometrics, …
- Philips Respironics, Inc.：市場シェア分析Philips Respironics, Inc. Market Share Analysis Summary GlobalData’s new report, “Philips Respironics, Inc. Market Share Analysis” provides in-depth information on Philips Respironics, Inc.’s market position in the different medical equipment markets it operates in. The report provides Philips Respironics, Inc. market share information in five key market categories – Anesthesia Machines, Respirato …
- クラウド式企業コンテンツ管理ソリューションの世界市場予測（～2022年）“Factors such as awareness about cloud-based ECM benefits among the enterprises and reduced operational and capital expenditure are some of the factors driving the cloud ECM market” The cloud Enterprise Content Management (ECM) market size is estimated to grow from USD 9.77 billion in 2017 to USD 34.42 billion by 2022, at a Compound Annual Growth Rate (CAGR) of 28.6%. The market is driven by facto …
- ヨーロッパのCEE高炉スラグ市場Statistics of the Central and Eastern Europe blast furnace slag market with detailed classifications, in terms of value and volume have been provided in this report. This market study provides a detailed qualitative and quantitative analysis of the Central and Eastern Europe blast furnace slag market. The report provides a comprehensive review of the major market drivers and restraints. The market …
- 成人用おむつの中東・アフリカ市場2019-2023About this marketThe rise in innovative product offerings is one of the key factors expected to trigger the adult diapers market growth in MEA during the forecast period. Product innovations are leading to the development of comfortable, thin adult diapers, convenient diapers with excessive retention capacity and increased fluid absorption. Vendors are also introducing several innovative designs o …
